Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by immune-based therapies.

During the primary infection the antibodies slowly increase, peak at around ten days and then gradually decrease. This primary infection results in the production of memory cells that remain in ...

The chikungunya virus virus-like particle vaccine is well tolerated and shows high immunogenicity in both previous recipients ...

PD-L2 could help to reduce the body's immune response against the transplanted stem cells ... Learn more here We endeavour to provide the community with real-time access to true unfiltered news ...

Early clinical results suggest the firm's antibodies targeting the Vβ T-cell receptor could induce strong and durable responses in cancer patients.

Researchers at Vaxart Inc. and the Center for Vaccine Development at the University of Maryland School of Medicine evaluated the safety and immunogenicity of an oral norovirus vaccine tablet, VXA ...